KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
77 hedge funds and large institutions have $366M invested in Chinook Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
38% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 26
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1M
Holders
77
Holding in Top 10
2
Calls
–
Puts
$1M
Top Buyers
| 1 | +$4.8M | |
| 2 | +$4.24M | |
| 3 | +$735K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$557K |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$522K |
Top Sellers
| 1 | -$4.33M | |
| 2 | -$3.17M | |
| 3 | -$2.44M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.55M |
| 5 |
Renaissance Technologies
New York
|
-$1.46M |